Abstract
F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has variable efficacy in evaluating hepatocellular carcinoma. We present a case of a new oncologic imaging tracer fluoromethylcholine (FCH), which has visualized recurrent multifocal hepatoma in a patient with a poor FDG avid hepatic tumour. The lesions demonstrated on FCH PET correlated well with the findings on CT hepatic angiography.
Original language | English (US) |
---|---|
Pages (from-to) | B299-B302 |
Journal | Australasian Radiology |
Volume | 51 |
Issue number | SUPPL. 4 |
DOIs | |
State | Published - Dec 2007 |
Keywords
- Fluorodeoxyglucose
- Fluoromethylcholine
- Hepatoma
- Positronemission tomography
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging